Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 76 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 5PO1CA094237-15
National Cancer Institute
Grant: P30 CA125123
National Institutes of Health
Grant: DK56338
CPRIT
Grant: RP170719
CPRIT
Grant: RP150578
NCI NIH HHS
Grant: P01 CA094237
NIGMS NIH HHS
Grant: T32 GM105538
NHLBI NIH HHS
Grant: T32 HL092332
NIDDK NIH HHS
Grant: P30 DK056338
National Institutes of Health
Grant: 5P01CA094237-10
CELL PROCESSING
National Institutes of Health
Grant: 5T32HL092332-17
Training In Cell and Gene Therapy
National Institutes of Health
Grant: 5P30DK056338-18
Texas Medical Center Digestive Diseases Center
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
National Heart Lung and Blood Institute
National Cancer Institute
CPRIT
FWCI
4.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models
Additional file 1 of Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models